4,4'-dimethyl-[1,1'-biphenyl]-2,2',5,5'-tetraol

Catalog No.: 
ACEYMA960
CAS No.: 
4371-34-0
Molecular Formula: 
C14H14O4
Molecular Weight: 
246.09
4,4'-dimethyl-[1,1'-biphenyl]-2,2',5,5'-tetraol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$97.00In stockInquiry
50mg95%$164.00In stockIn stock
100mg95%$279.00In stockIn stock
250mg95%$530.00In stockIn stock
1g95%$2014.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4'-dimethyl-[1,1'-biphenyl]-2,2',5,5'-tetraol
IUPAC Name4,4'-dimethyl-[1,1'-biphenyl]-2,2',5,5'-tetraol
Molecular FormulaC14H14O4
Molecular Weight246.09
SMILESOC1=CC(C)=C(C=C1C2=C(O)C=C(C)C(O)=C2)O
InChI KeyDSVRCBOSZSZMRX-UHFFFAOYSA-N
Synonym2-(2,5-dihydroxy-4-methyl-phenyl)-5-methyl-hydroquinone | NCGC00013025 | NCIStruc1_000270 | NSC2805 | NSC-2805 | HY-134417 | BCP29786 | cid_220284 | 2-(2,5-dihydroxy-4-methylphenyl)-5-methylbenzene-1,4-diol | 4,4'-Dimethyl-[1,1'-biphenyl]-2,2',5,5'-tetrao
CAS No.4371-34-0
PubChem CID220284

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACEYMA960 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEYMA960 route product structure diagram
    ACEYMA9604371-34-0In Stock
Inquiry

2. ACEYMA960 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEYMA960 route product structure diagram
    ACEYMA9604371-34-0In Stock
Inquiry

3. ACEYMA960 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEYMA960 route product structure diagram
    ACEYMA9604371-34-0In Stock
Inquiry

Comments (0)